What is the recommended dose of Benadryl (diphenhydramine) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Diphenhydramine Dosing

For children 6 years and older, administer 1-2 mg/kg per dose (maximum 50 mg) every 4-6 hours, not exceeding 6 doses in 24 hours; for children under 6 years, the FDA-approved dosing is 10 mL (25 mg) for ages 6 to under 12 years, while children under 6 years should not use over-the-counter diphenhydramine without physician direction. 1

Standard Pediatric Dosing by Age and Weight

Children 6 to Under 12 Years

  • Dose: 10 mL (25 mg) every 4-6 hours 1
  • Alternative weight-based dosing: 1-2 mg/kg per dose, maximum 50 mg 2
  • Maximum: 6 doses in 24 hours (not to exceed 300 mg daily) 3, 1

Children Under 6 Years

  • FDA labeling: "Do not use" for over-the-counter administration 1
  • Physician-directed dosing: 1-2 mg/kg per dose when medically indicated 2
  • Toxic threshold: Ingestions ≥7.5 mg/kg warrant emergency department evaluation 4, 5

Adolescents (12 Years and Older)

  • Dose: 25-50 mg every 4-6 hours 3, 1
  • Maximum: 300 mg in 24 hours 3

Route Selection Based on Clinical Context

Oral Administration

  • Liquid formulations are preferred over tablets for acute allergic reactions requiring rapid absorption 2, 3
  • Onset: 20-30 minutes PO 2
  • Peak effect: 45-60 minutes PO 2
  • Duration: 4-6 hours 2, 3

Parenteral Administration (IM/IV)

  • Use when: Patient cannot tolerate oral medications, rapid symptom control needed, or treating anaphylaxis as adjunctive therapy 2, 3
  • Dose: 1-2 mg/kg per dose, maximum 50 mg 2
  • Onset: 5-10 minutes IV, 15 minutes IM 2
  • Peak effect: 30 minutes IV, 1 hour IM 2

Critical Clinical Context: When Diphenhydramine is NOT First-Line

Diphenhydramine should NEVER be used as monotherapy for anaphylaxis. 3

Anaphylaxis Treatment Algorithm

  1. First-line: Epinephrine 0.01 mg/kg IM (maximum 0.3 mg for children <25 kg, 0.5 mg for ≥25 kg) 2
  2. Adjunctive therapy (after epinephrine):
    • Diphenhydramine 1-2 mg/kg (maximum 50 mg) IV or oral 2
    • Consider H2-antagonist (ranitidine 1 mg/kg, maximum 75-150 mg) 2
    • Corticosteroids (methylprednisolone 1 mg/kg, maximum 60-80 mg) 2
  3. Supportive measures: Recumbent positioning, oxygen, IV fluids, albuterol for bronchospasm 2

Special Clinical Situations

Chemical Restraint for Agitation (Ages 6-12 Years)

  • Combination therapy: Haloperidol 0.1 mg/kg PO/IM/IV + diphenhydramine 0.1 mg/kg PO/IM/IV 2
  • May repeat every 20-30 minutes as needed 2
  • Purpose: Diphenhydramine reduces extrapyramidal symptoms from antipsychotics 2

Acute Urticaria

  • Diphenhydramine 1-2 mg/kg every 4-6 hours 2, 3
  • Consider combination with H2-antagonist for superior efficacy 2

Important Safety Considerations and Pitfalls

Toxicity Threshold

  • Children <6 years: Ingestions ≥7.5 mg/kg require emergency department evaluation 4, 5
  • Children ≥6 years: Ingestions ≥7.5 mg/kg OR ≥300 mg (whichever is less) require emergency department evaluation 4
  • In a validation study of 305 children under 6 years, 99.7% who ingested <7.5 mg/kg had no serious clinical effects 5

Common Adverse Effects

  • Sedation is the most common side effect (reported in 95% of pediatric subjects in pharmacokinetic studies) 6
  • Other effects: dizziness, blurred vision, dry mouth, hypotension, urinary retention 3
  • Paradoxical excitation can occur, especially in younger children 2

Contraindications to Home Management

  • Refer to emergency department if: Agitation, hallucinations, seizures, abnormal muscle movements, loss of consciousness, respiratory depression, or any moderate-to-severe symptoms beyond mild drowsiness 4
  • Suicidal intent, intentional abuse, or suspected malicious intent (child abuse) 4

Drug Interactions

  • Enhanced sedation with alcohol, benzodiazepines, or opioid narcotics 3
  • Anticholinergic effects may worsen delirium from other anticholinergic drugs 2

Pharmacokinetic Considerations

Weight-age dosing schedules achieve more consistent drug exposure across pediatric age groups than simple age-based dosing. 6

  • After allometric scaling for body weight, no maturation-related changes in clearance were observed across ages 2-17 years 6
  • Over an 8-fold dose range (6.25-50 mg), Cmax and AUC increased only 90-140% across age groups, with similar time to peak (1.5 hours) 6
  • This supports weight-based dosing (1-2 mg/kg) as more physiologically appropriate than fixed age-based dosing 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.